Altered Gut Microbiota Composition and Its Potential Association in Patients with Advanced Hepatocellular Carcinoma
Open Access
- 2 February 2023
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 30 (2) , 1818-1830
Abstract
Hepatocellular carcinoma (HCC) is the second-most-common cause of cancer death. In recent years, studies have suggested that intestinal microbiota dysregulation is closely related to HCC and can affect the therapeutic efficacy of immune checkpoint inhibitors. However, there are few data on the relationship between altered gut microbiota composition and its potential association in patients with advanced hepatocellular carcinoma. Hence, in this study, we aimed to investigate the gut microbiota profile associated with advanced hepatocarcinoma. In total, 20 patients with advanced hepatocarcinoma and 20 matched healthy participants were recruited. Stool samples were collected for 16S rRNA sequencing to confirm intestinal microbiota dysbiosis. The results showed that the Nseqs index in advanced hepatocarcinoma patients was significantly different compared with that in healthy individuals, while the butyrate-producing bacteria decreased and LPS-producing bacteria increased. Meanwhile, Lactobacillus, Anaerostipes, Fusicatenibacter, Bifidobacterium, and Faecalibacterium were significantly correlated with AFP, ALT, AST, and PIVKA. Our findings characterized the gut microbiota composition of advanced hepatocarcinoma, providing an experimental basis and theoretical support for using microbiota to regulate immunotherapy, achieve potential biomarkers for diagnosis, and improve the effect of clinical treatment for patients with advanced hepatocarcinoma.Keywords
Funding Information
- National Natural Science Foundation of China (82102468, 2022J011043)
- Natural Science Foundation of Fujian Province (82102468, 2022J011043)
This publication has 34 references indexed in Scilit:
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacyScience, 2015
- Proteobacteria: microbial signature of dysbiosis in gut microbiotaTrends in Biotechnology, 2015
- The evolving epidemiology of hepatocellular carcinoma: a global perspectiveExpert Review of Gastroenterology & Hepatology, 2015
- Targeting gut flora to prevent progression of hepatocellular carcinomaJournal of Hepatology, 2013
- Metagenomic Analyses of Alcohol Induced Pathogenic Alterations in the Intestinal Microbiome and the Effect of Lactobacillus rhamnosus GG TreatmentPLOS ONE, 2013
- Using network analysis to explore co-occurrence patterns in soil microbial communitiesThe ISME Journal, 2011
- Metagenomic biomarker discovery and explanationGenome Biology, 2011
- Intestinal Microbiota Was Assessed in Cirrhotic Patients with Hepatitis B Virus InfectionMicrobial Ecology, 2011
- Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial CommunitiesApplied and Environmental Microbiology, 2009
- Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestineFEMS Microbiology Letters, 2009